Follows patients treated with BALT devices for brain artery conditions
Collects follow-up data on BALT devices used for brain artery disease.
Key facts
- Who runs it
- Balt Extrusion
- Where
- Angers, Bordeaux, La Tronche, Lille, Paris, and Tours, FranceSee the 6 sitesAlso in 2 other countries, 6 sites
- Trial code
- Registry title
- Safety, Performance and Usability of BALT Medical Devices: The EVIDENCE Post Marketing Clinical Follow-up Platform
- Status
- Recruiting
- People taking part
- 10,000 people, planned
- Started
- 12 Jul 2021
- Expected to end
- Oct 2041
- Type of study
- Observational
- Treatments tested
- BALT medical devices
- Record updated
- 18 September 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
This platform collects follow-up data on people treated with BALT medical devices for blood vessel conditions in the brain or body. The record lists only consent as an inclusion rule.
- Age
- 2 years and older
- Sex
- All sexes can join
Main reasons for not taking part
- Device used in several procedures (two or more diseases treated in the same procedure)
- Contra-indications of each device listed in its instructions for use
The registry criteria, word for word
Show all 3 criteriaShow less
Who can take part
- Provision of a signed, written and dated informed consent or non-opposition (where applicable)
Who cannot take part
- Device(s) used in multiple procedures (two, or more, pathologies treated during the same procedure)
- Contra-indications of each device as described in the instructions for use
Where in France
Also in 2 other countries, 6 sites
- CHU AngersAngers, FranceContact: Anne PASCO PAPON, MD (principal investigator)Taking people
- CHU BordeauxBordeaux, FranceContact: Tristan KERDRAONTaking people
- Chu Grenoble AlpesLa Tronche, FranceContact: Kamel Boubagra, MD (principal investigator)Taking people
- Hopital Roger SalengroLille, FranceContact: Nicolas Bricout, MD (principal investigator)Taking people
- Kremlin Bicêtre - APHPParis, FranceContact: Julien DUCASSETaking people
- CHU ToursTours, FranceContact: Dr BibiTaking people
About the trial
What the trial wants to find out
BALT has designed an electronic platform to continue collecting clinical data as part of the post-marketing clinical follow-up of its devices.
Read full original descriptionShow less
This platform is purely exploratory, without hierarchical order of the objectives and associated outcomes.
The group in the trial
- BALT medical devices
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Safety, Performance and Usability of BALT Medical Devices: The EVIDENCE Post Marketing Clinical Follow-up Platform. An International, Multicenter, Prospective, and Retrospective Data Collection
- Plain-language title
- Follows patients treated with BALT devices for brain artery conditionsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 18 September 2025